Muhamed Baljević

Statistics

Publications

Citations

2.9K

H-Index

Active since

2008

Affiliations

University of Wisconsin Carbone Cancer Center(Current)

University of Nebraska Medical Center

Karyopharm Therapeutics (United States)

University of California, Los Angeles

Dalhousie University

Muhamed Baljević is an author at University of Wisconsin Carbone Cancer Center specializing in multiple myeloma therapy, hematologic malignancy therapy, and multiple myeloma.

ORCID

Publications per year

2008–2025

Publications

CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumors

Sergey V. Shmelkov, Jason M. Butler, Andrea T. Hooper et al. · Journal of Clinical Investigation · 2008 · 890 citations

Medicine, Cell Biology, Oncology +16

Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive–like behaviors in mice

Sergey V. Shmelkov, Adı́lia Hormigo, Deqiang Jing et al. · Nature Medicine · 2010 · 361 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology

Shaji Kumar, Natalie S. Callander, Kehinde Adekola et al. · Journal of the National Comprehensive Cancer Network · 2020 · 277 citations

Medicine, Hematology, Oncology +17

Mutational Cooperativity Linked to Combinatorial Epigenetic Gain of Function in Acute Myeloid Leukemia

Alan H. Shih, Yanwen Jiang, Cem Meydan et al. · Cancer Cell · 2015 · 247 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +16

NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022

Natalie S. Callander, Muhamed Baljević, Kehinde Adekola et al. · Journal of the National Comprehensive Cancer Network · 2022 · 210 citations

Medicine, Hematology, Oncology +13

1–5 of 33